Evo
A family is a named generation or product line. Scores below are the sum of its named releases and any documented internal systems in the same line.
Benefit
+1.91
Harm
0.00
Net Good
1.91
Releases
Leaderboard
| Rank | Model | Organization | Benefit | Harm | Net | Events | Last impact |
|---|---|---|---|---|---|---|---|
| 26 | Evo | Arc Institute | +1.67 | 0.00 | 1.67 | 1 | 14 Nov 2024 |
| 54 | Evo 2 | Arc Institute | +0.24 | 0.00 | 0.24 | 1 | 19 Feb 2025 |
Timeline
- Benefit
- Harm
- Net
Events
Benefit19 Feb 2025
Evo 2 extends genomic language modeling across domains of life
Arc Institute released Evo 2 on 19 February 2025 as a larger DNA foundation model trained across eukaryotic and prokaryotic genomes, with public weights and reports of improved variant-effect and sequence-generation behavior versus Evo 1.
BiologyprovisionalTier 2 Notable+0.24
Benefit14 Nov 2024
Evo designs functional CRISPR-Cas and transposon systems from DNA
Arc Institute and Stanford’s Evo genomic model, published in Science on 14 November 2024, generated protein–RNA and protein–DNA systems that showed activity in experimental tests.
BiologyverifiedTier 3 Major+1.67